Suppression of withdrawal symptoms by dynorphin in heroin addicts

Eur J Pharmacol. 1982 Aug 27;82(3-4):183-6. doi: 10.1016/0014-2999(82)90509-x.

Abstract

The effectiveness of dynorphin-(1-13) in suppressing heroin withdrawal was studied. At a dose of 60 micrograms/kg body weight, dynorphin-(1-13) was effective in suppressing withdrawal symptoms. When saline was administered a strong placebo effect was noticed that, however, did not influence the outcome of the results. Only three out of the twelve patients receiving dynorphin-(1-13) experienced some mild side-effects such as feeling warm, dizziness and precordial formication.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Clinical Trials as Topic
  • Double-Blind Method
  • Dynorphins
  • Endorphins / administration & dosage
  • Endorphins / therapeutic use*
  • Heroin Dependence / complications*
  • Humans
  • Male
  • Substance Withdrawal Syndrome / prevention & control*

Substances

  • Endorphins
  • Dynorphins